OptConnect Completes Add-on Acquisition of Capestone to Expand Global Connectivity Solutions
2.10.2024 14:00:00 CEST | Business Wire | Press release
Expanding Reach Across Europe and Strengthening its Position as a Global Provider
OptConnect, a leader in managed wireless services, today announced it has acquired Netherlands-based Capestone, a provider of 4G and 5G IoT solutions across Europe. Capestone follows the acquisition of Premier Wireless Solutions and M2M DataGlobal, which were completed in November 2021 and January 2024, respectively. Together these businesses create a premier global managed wireless connectivity platform of scale, capable of supporting customers across multiple industries and solution needs around the world.
The Capestone acquisition significantly increases OptConnect’s global coverage and enhances the number of end markets and verticals that the combined business can support. Capestone adds a rich legacy of hardware relationships along with a proprietary set of IoT software, services, and connectivity bundled together under the Comgate brand. In terms of reach, Capestone is active in more than 60 countries and supports over 1,000 channel partners and enterprises.
Headquartered in Leiden, Netherlands, Capestone has spent 15 years perfecting IoT solutions including robust mobile internet solutions, IoT networks, and critical communications across diverse industries. These include — but are not limited to — healthcare, transportation, maritime, construction, industrial IoT, retail, and surveillance. Capestone and OptConnect share a customer-centric model that simplifies connectivity while providing a wide range of managed services. With fully managed solutions, customers can focus on core business decisions instead of managing their cellular devices. Capestone has many local carrier relationships to support customers with a variety of solutions and competitive rate plans throughout Europe and beyond.
In January of 2024, OptConnect acquired M2M DataGlobal, expanding its reach and services into Latin America. Collectively, OptConnect, M2M DataGlobal, and Capestone provide managed wireless services to more than 10,000 unique customers across the globe.
“This new partnership is a key step in strengthening our global presence,” said Chris Baird, CEO of OptConnect. “With the addition of Capestone, OptConnect can now significantly expand its capabilities in Europe and provide more seamless and reliable wireless connectivity solutions worldwide. Our focus remains on empowering customers to achieve their IoT goals, and this strategic move ensures we can continue delivering value and innovation on a global scale.”
Capestone will continue to operate under the Capestone name at its European headquarters in Leiden, Netherlands. The company will also continue operations in Dusseldorf, Germany and London, United Kingdom. Jos Ouwerkerk will continue as Managing Director of the Capestone business unit.
“Our company has always prioritized delivering cutting-edge connectivity solutions to meet the evolving demands of our customers,” said Jos Ouwerkerk, Managing Director of Capestone. “By joining forces with OptConnect, we’re not only expanding our reach but also enhancing our ability to provide even more innovative and scalable IoT solutions. This partnership allows us to leverage OptConnect’s global experience while continuing to deliver the exceptional service and tailored solutions our customers have come to expect.”
For more information on Capestone, please visit https://capestone.com/en/. For more information about OptConnect, please visit www.optconnect.com.
About Capestone
Headquartered in Leiden, Netherlands, Capestone is a provider of managed connectivity solutions and related hardware for IoT applications serving high-growth industries, including healthcare, industrial IoT, and transportation, among others. Primarily serving the Netherlands, the UK, and Germany, Capestone is a leading, differentiated connectivity provider that has established relationships with top hardware distributors and international carriers across Europe.
About OptConnect
Since its beginnings in 2009, OptConnect has emerged as a leading provider of cellular connectivity services for a wide variety of industries and applications, including security systems, ATMs, wireless kiosks, micro markets, smart safes, digital signage, parking and mobility, irrigation systems, and many other M2M applications. Many thousands of customers across the globe rely on OptConnect for its ‘easy button’ approach, plug-and-play hardware, managed services, and world-class customer care.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241002824454/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom